home / stock / asln / asln quote
Last: | $0.6152 |
---|---|
Change Percent: | 3.33% |
Open: | $0.61 |
Close: | $0.6152 |
High: | $0.6477 |
Low: | $0.59 |
Volume: | 470,365 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6152 | $0.61 | $0.6152 | $0.6477 | $0.59 | 470,365 | 03-28-2024 |
$0.631 | $0.629 | $0.631 | $0.65 | $0.604 | 244,142 | 03-27-2024 |
$0.635 | $0.65 | $0.635 | $0.65001 | $0.5814 | 397,296 | 03-26-2024 |
$0.6533 | $0.6699 | $0.6533 | $0.6875 | $0.5821 | 631,094 | 03-25-2024 |
$0.653 | $0.73 | $0.653 | $0.73 | $0.649 | 426,273 | 03-22-2024 |
$0.6951 | $0.6981 | $0.6951 | $0.72 | $0.684 | 386,354 | 03-21-2024 |
$0.709 | $0.71 | $0.709 | $0.72 | $0.6514 | 420,810 | 03-20-2024 |
$0.7099 | $0.773 | $0.7099 | $0.809 | $0.67 | 1,132,632 | 03-19-2024 |
$0.7995 | $0.68 | $0.7995 | $0.8 | $0.64 | 1,773,390 | 03-18-2024 |
$0.65 | $0.625 | $0.65 | $0.6869 | $0.5955 | 992,606 | 03-15-2024 |
$0.625 | $0.7 | $0.625 | $0.7399 | $0.5536 | 2,419,421 | 03-14-2024 |
$0.7499 | $0.71 | $0.7499 | $0.94 | $0.651 | 4,864,700 | 03-13-2024 |
$0.685 | $1.62 | $0.685 | $2.09 | $0.66 | 13,059,481 | 03-12-2024 |
$1.63 | $0.626 | $1.63 | $1.9 | $0.626 | 25,317,197 | 03-11-2024 |
$0.625 | $0.638 | $0.625 | $0.664 | $0.621 | 52,336 | 03-08-2024 |
$0.64 | $0.69 | $0.64 | $0.73 | $0.62 | 228,373 | 03-07-2024 |
$0.669 | $0.611 | $0.669 | $0.7419 | $0.611 | 200,485 | 03-06-2024 |
$0.5816 | $0.63 | $0.5816 | $0.6449 | $0.5801 | 100,650 | 03-05-2024 |
$0.645 | $0.71 | $0.645 | $0.7404 | $0.64 | 139,917 | 03-04-2024 |
$0.7142 | $0.9 | $0.7142 | $0.9 | $0.71 | 345,818 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
ASLAN Pharmaceuticals Limited Company Name:
ASLN Stock Symbol:
NASDAQ Market:
SAN MATEO, Calif. and SINGAPORE, March 27, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceutical (NASDAQ:ASLN), a clinical-stage, immunology-focused bio...
SAN MATEO, Calif. and SINGAPORE, March 27, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceutical (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that management will give a virtual company ...
Bitdeer Technologies Group (BTDR) is expected to report $0.11 for Q4 2023 BioForce Nanosciences Holdings Inc (BFNH) is expected to report for Q4 2023 Casino Guichard Perrachon ADR (CGUSY) is expected to report for quarter end 2023-12-31 Motorsport Games Inc. (MSGM) is expected to repo...